Clinical data | |
---|---|
Other names | Lithium succinate dibasic |
AHFS/ Drugs.com | Monograph |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
ECHA InfoCard | 100.163.153 |
Chemical and physical data | |
Formula | C4H4Li2O4 |
Molar mass | 129.95 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Lithium succinate (C4H4Li2O4), the dilithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis [1] and proposed for the treatment of anogenital warts. [2]
Clinical data | |
---|---|
Other names | Lithium succinate dibasic |
AHFS/ Drugs.com | Monograph |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
ECHA InfoCard | 100.163.153 |
Chemical and physical data | |
Formula | C4H4Li2O4 |
Molar mass | 129.95 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Lithium succinate (C4H4Li2O4), the dilithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis [1] and proposed for the treatment of anogenital warts. [2]